ID   ZL5
AC   CVCL_5907
DR   ECACC; 11120715
DR   Wikidata; Q54995957
RX   PubMed=1373705;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Doubling time: 31 hours (PubMed=1373705).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=11120715
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   PubMed=1373705; DOI=10.1002/ijc.2910510220;
RA   Schmitter D., Lauber B., Fagg B., Stahel R.A.;
RT   "Hematopoietic growth factors secreted by seven human pleural
RT   mesothelioma cell lines: interleukin-6 production as a common
RT   feature.";
RL   Int. J. Cancer 51:296-301(1992).
//